Skip to content Skip to footer

Glossary – PSYCH: The Psychedelics As Medicine Report 3rd Edition

Glossary – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Share this story

Definitions of key acronyms and terms used throughout The Psychedelics as Medicine Report.

A

ACT
acceptance and commitment therapy
ADHD
attention deficit hyperactivity disorder
AUD
alcohol use disorder

B

BTD
Breakthrough Therapy designation

C

CBCT
Cognitive behavioural cognitive therapy
CBT
Cognitive behavioural therapy
CIIS
California Institute of Integral Studies
CSE
Canadian Stock Exchange
CNS
central nervous system

D

DALYs
disability adjusted life years
DEA
Drug Enforcement Administration
DMT
Dimethyltryptamine
DSCP
Drug software combination products

E

ECT
electroconvulsive therapy
EDs
eating disorders
EEG
electroencephalogram
EMA
European Medicine Agency

F

FDA
Food and Drug Administration
fMRI
functional magnetic resonance imaging

G

GITA
Global ibogaine therapy alliance
GMP
Good Manufacturing Practice

I

ICL
Imperial College London
IND
investigational new drug
IM
intramuscular
IP
intellectual property
IPO
initial public offering
IV
intravenous

L

LSD
lysergic acid diethylamide

M

MAOIs
monoamine oxidase inhibitors
MAPS
Multidisciplinary Association for Psychedelic Studies
MAPS PBC
Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation
MDD
major depressive disorder
MDMA
methylenedioxymethamphetamine
MMA
Mind Medicine Australia

N

NGO
non-government organisation
NHS
National Health Service

O

OCD
obsessive-compulsive disorder
OUD
opioid use disorder

P

PAT
psychedelic assisted therapy
PPD
postpartum depression
PTSD
post-traumatic stress disorder

R

RCT
randomised controlled trial

S

SI
suicidal ideation
SNRIs
serotonin and norepinephrine reuptake inhibitors
SSRIs
selective serotonin reuptake inhibitors
SUD
substance use disorder

T

TBI
traumatic brain injury
TGA
Therapeutic Goods Administration
TRD
treatment-resistant depression

U

UCLA
University of California, Los Angeles

V

VR
virtual reality

W

WHO
World Health Organisation
Prefer the full dataset? Download the complete report (PDF).
Recent posts
December 18, 2025
Psychedelic Research: Clinical Trials, Timelines, and Key Research Groups – PSYCH: The Psychedelics As Medicine Report 3rd Edition
December 18, 2025
Therapy Practitioners in Psychedelic-Assisted Therapy – PSYCH: The Psychedelics As Medicine Report 3rd Edition
December 18, 2025
Patents and Intellectual Property in Psychedelic Medicine – PSYCH: The Psychedelics As Medicine Report 3rd Edition
December 18, 2025
Psychedelics and the Law: How Regulation Is Beginning to Change – PSYCH: The Psychedelics As Medicine Report 3rd Edition

Catch up on our newest articles that you might have missed

louis-reed-pwcKF7L4-no-unsplash (1)
December 18, 2025
Psychedelic Research: Clinical Trials, Timelines, and Key Research Groups – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...
stephen-isaiah-nHOIBmZ9Gkw-unsplash
December 18, 2025
Therapy Practitioners in Psychedelic-Assisted Therapy – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...
scott-graham-OQMZwNd3ThU-unsplash
December 18, 2025
Patents and Intellectual Property in Psychedelic Medicine – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...
inaki-del-olmo-NIJuEQw0RKg-unsplash
December 18, 2025
Psychedelics and the Law: How Regulation Is Beginning to Change – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact